Revolution Medicines to Report Financial Results for Second Quarter 2026 After Market Close on August 5, 2026

Go back to Revolution Medicines to Report Financial Results for Second Quarter 2026 After Market Close on August 5, 2026
(NASDAQ: RVMD) Delayed: 210.02 -0.85 (0.4%)
Previous Close $210.87    52 Week High
Open $209.01    52 Week Low
Day High $211.75    P/E N/A 
Day Low $207.48    EPS
Volume 885,062